Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
Clin J Am Soc Nephrol. 2023 Nov 1;18(11):1416-1425. doi: 10.2215/CJN.0000000000000257. Epub 2023 Aug 3.
Sickle cell trait affects approximately 8% of Black individuals in the United States, along with many other individuals with ancestry from malaria-endemic regions worldwide. While traditionally considered a benign condition, recent evidence suggests that sickle cell trait is associated with lower eGFR and higher risk of kidney diseases, including kidney failure. The mechanisms underlying these associations remain poorly understood. We used proteomic profiling to gain insight into the pathobiology of sickle cell trait.
We measured proteomics ( N =1285 proteins assayed by Olink Explore) using baseline plasma samples from 592 Black participants with sickle cell trait and 1:1 age-matched Black participants without sickle cell trait from the prospective Women's Health Initiative cohort. Age-adjusted linear regression was used to assess the association between protein levels and sickle cell trait.
In age-adjusted models, 35 proteins were significantly associated with sickle cell trait after correction for multiple testing. Several of the sickle cell trait-protein associations were replicated in Black participants from two independent cohorts (Atherosclerosis Risk in Communities study and Jackson Heart Study) assayed using an orthogonal aptamer-based proteomic platform (SomaScan). Many of the validated sickle cell trait-associated proteins are known biomarkers of kidney function or injury ( e.g. , hepatitis A virus cellular receptor 1 [HAVCR1]/kidney injury molecule-1 [KIM-1], uromodulin [UMOD], ephrins), related to red cell physiology or hemolysis (erythropoietin [EPO], heme oxygenase 1 [HMOX1], and α -hemoglobin stabilizing protein) and/or inflammation (fractalkine, C-C motif chemokine ligand 2/monocyte chemoattractant protein-1 [MCP-1], and urokinase plasminogen activator surface receptor [PLAUR]). A protein risk score constructed from the top sickle cell trait-associated biomarkers was associated with incident kidney failure among those with sickle cell trait during Women's Health Initiative follow-up (odds ratio, 1.32; 95% confidence interval, 1.10 to 1.58).
We identified and replicated the association of sickle cell trait with a number of plasma proteins related to hemolysis, kidney injury, and inflammation.
镰状细胞特征影响了大约 8%的美国黑人,以及世界上许多来自疟疾流行地区的其他个体。虽然传统上认为这是一种良性疾病,但最近的证据表明,镰状细胞特征与较低的 eGFR 和更高的肾脏疾病风险有关,包括肾衰竭。这些关联的机制仍知之甚少。我们使用蛋白质组学谱分析来深入了解镰状细胞特征的病理生物学。
我们使用前瞻性妇女健康倡议队列中 592 名镰状细胞特征的黑人参与者和 1:1 年龄匹配的无镰状细胞特征的黑人参与者的基线血浆样本进行蛋白质组学(通过 Olink Explore 检测 1285 种蛋白质)测量。使用年龄调整的线性回归来评估蛋白质水平与镰状细胞特征之间的关联。
在年龄调整模型中,在经过多次测试校正后,有 35 种蛋白质与镰状细胞特征显著相关。在使用正交适体蛋白质组学平台(SomaScan)检测的两个独立队列(社区动脉粥样硬化风险研究和杰克逊心脏研究)中的黑人参与者中,有几个镰状细胞特征-蛋白质关联得到了复制。许多验证的镰状细胞特征相关蛋白质是肾脏功能或损伤的已知生物标志物(例如,甲型肝炎病毒细胞受体 1 [HAVCR1]/肾脏损伤分子 1 [KIM-1]、尿调蛋白 [UMOD]、促红细胞生成素 [EPO]、血红素加氧酶 1 [HMOX1] 和 α-血红蛋白稳定蛋白)和/或炎症( fractalkine、C-C 基序趋化因子配体 2/单核细胞趋化蛋白-1 [MCP-1] 和尿激酶纤溶酶原激活物表面受体 [PLAUR])。从顶级镰状细胞特征相关生物标志物构建的蛋白质风险评分与妇女健康倡议随访期间镰状细胞特征患者的肾脏衰竭事件相关(比值比,1.32;95%置信区间,1.10 至 1.58)。
我们确定并复制了镰状细胞特征与一些与溶血、肾脏损伤和炎症相关的血浆蛋白之间的关联。